GLP-1 Agonists and Pancreatitis Risk
US$ 22.75
side effects of glp 1 agonists Your guide to GLP-1 common side effects of GLP-1
Description
Wegovy (semaglutide), which was approved in 2021 (it was previously available for diabetes as Ozempic and in an oral form for diabetes as Rybelsus)
Since this discovery, GLP-1 receptors have been identified in a number of tissues, including the GI tract, pancreas, brain, lung, and kidney
These results suggest PI3K/Akt/mTOR signaling mediated the protection of GLP-1 on apoptosis in neurons (193)
Cannon CP, Pratley R, Dagogo-Jack S et al (2020) Cardiovascular outcomes with ertugliflozin in type 2 diabetes
